Navigation Links
ViroPharma To Release 2012 Second Quarter Financial Results On August 9, 2012
Date:7/24/2012

EXTON, Pa., July 24, 2012 /PRNewswire/ -- ViroPharma Incorporated's (Nasdaq: VPHM) second quarter financial results for 2012 are expected to be released no later than Thursday, August 9, 2012.  In light of the August 9th PDUFA date for industrial scale expansion of Cinryze® (C1 esterase inhibitor [human]), the company has chosen to align the two events. In the event the company receives a response from the FDA prior to August 9th, the company will announce the specific timing of the conference call upon receipt of the FDA response.

During the conference call, ViroPharma management will discuss the 2012 second quarter financial results and other business including the FDA decision regarding industrial scale expansion of Cinryze.

The press release and the live webcast of the conference call will be accessible via ViroPharma's corporate website at http://www.viropharma.com.  An audio archive will be available at the same address until August 23, 2012.  To participate in the conference call, please dial (800) 874-4559 (domestic) and (302) 607-2019 (international).  After placing the call, please tell the operator you wish to join the ViroPharma investor conference call. 

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options.  ViroPharma is developing a portfolio of therapeutics for rare and Orphan diseases including C1 esterase inhibitor deficiency, Friedreich's Ataxia, and adrenal insufficiency; and recurrent C. difficile infection (CDI).  Our goal is to provide rewarding careers to employees, to create new standards of care in the way serious diseases are treated, and to build international partnerships with the patients, advocates, and health care professionals we serve.  ViroPharma's commercial products address diseases including hereditary angioedema (HAE), seizures and C. difficile-associated diarrhea (CDAD); for full U.S. prescribing information on our products, please download the package inserts at http://www.viropharma.com/Products.aspx; the prescribing information for other countries can be found at www.viropharma.com

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Berger & Montague, P.C. Reminds Viropharma Shareholders That The Deadline To Petition The Court To Act As Lead Plaintiff Is July 23, 2012
2. ViroPharma To Participate In The JMP Securities Healthcare Conference
3. Faruqi & Faruqi, LLP Announces Investigation of ViroPharma Incorporated
4. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
5. Kraton Performance Polymers, Inc. Announces Second Quarter 2012 Earnings Release Conference Call and Webcast and 2012 Investor Day and Webcast
6. Top 100 Drug Sales Data Released - Plavix Leads the Way
7. Berkery Noyes Releases First Half 2012 M&A Report For the Healthcare/Pharma Information and Technology Industry
8. Medica Announces Global Release of the EasyCell Assistant Analyzer for Hematology Laboratories
9. Merit Medical Systems Announces Earnings Release Date/Time And Conference Call Information For The Second Quarter Ended June 30, 2012
10. Span-America Medical Systems To Release Third Quarter Results On August 2, 2012
11. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017 The global preparative and process chromatography ... 2021 from USD 5.49 billion in 2016, at a ... of type, the preparative and process chromatography market is ... the process chromatography segment is expected to account for ... chromatography. Growth in this segment can primarily be attributed ...
(Date:2/16/2017)... , Feb. 16, 2017  Express Scripts (NASDAQ: ... the World,s Most Admired Companies within the Health Care: Pharmacy and ... named one of the World,s Most Admired Companies," said Tim ... by the commitment and passion of our 26,000 employees to make ... serve." ...
(Date:2/16/2017)... and SCOTTSDALE, Ariz. , Feb. ... Health Information Exchange (HIE), announced today it is partnering ... platform. HealthInfoNet,s HIE contains 98% of all Maine ... Maine hospitals and over 500 ambulatory ... of Directors, HealthInfoNet plans to deploy Orion Health,s Amadeus ...
Breaking Medicine Technology:
(Date:2/19/2017)... (PRWEB) , ... February 19, 2017 , ... ProBrand Glitch is a set of 30 ... ProBrand Glitch users can easily reveal any logo with a glitch reveal in just a ... control over the style and animation of each preset. Use these presets to add a ...
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken Matthews to visit its ... products. Ken was impressed with the safety and reliability of the Stannah Stairlift ... his show. This endorsement by Ken Matthews can be heard on News Radio ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... Smiles by ... Shopping Center in Davidson, NC. Dr. Brian Seese leads the practice as a skilled ... services under one roof. Smiles by Seese serves patients of all ages with excellence ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Reimbursement , **An FDAnews Webinar**, Feb. 22, 2017 — 1:30 p.m. – ... reimbursement questions manufacturers should be asking before selecting an FDA approval pathway? ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program ... , Trinity Health and the U.S. Soccer Foundation announced today that they have ... communities. Soccer for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals ...
Breaking Medicine News(10 mins):